These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor. Albuquerque EX; Tsai MC; Aronstam RS; Eldefrawi AT; Eldefrawi ME Mol Pharmacol; 1980 Sep; 18(2):167-78. PubMed ID: 6252436 [No Abstract] [Full Text] [Related]
4. Voltage- and time-dependent actions of piperocaine on the ion channel of the acetylcholine receptor. Tiedt TN; Albuquerque EX; Bakry NM; Eldefrawi ME; Eldefrawi AT Mol Pharmacol; 1979 Nov; 16(3):909-21. PubMed ID: 316855 [No Abstract] [Full Text] [Related]
5. Estimation of the dissociation constant of d-tubocurarine and the receptor for endogenous acetylcholine. Bowen JM J Pharmacol Exp Ther; 1972 Nov; 183(2):333-40. PubMed ID: 4343415 [No Abstract] [Full Text] [Related]
6. Interactions of gephyrotoxin with the acetylcholine receptor-ionic channel complex. I. Blockade of the ionic channel. Souccar C; Varanda WA; Daly JW; Albuquerque EX Mol Pharmacol; 1984 May; 25(3):384-94. PubMed ID: 6328264 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of amantadine. I. Interaction of the N-alkyl analogues with the ionic channels of the nicotinic acetylcholine receptor and electrically excitable membrane. Warnick JE; Maleque MA; Bakry N; Eldefrawi AT; Albuquerque EX Mol Pharmacol; 1982 Jul; 22(1):82-93. PubMed ID: 6126806 [TBL] [Abstract][Full Text] [Related]
8. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction. Maleque MA; Souccar C; Cohen JB; Albuquerque EX Mol Pharmacol; 1982 Nov; 22(3):636-47. PubMed ID: 6296656 [TBL] [Abstract][Full Text] [Related]
9. Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects. Aguayo LG; Warnick JE; Maayani S; Glick SD; Weinstein H; Albuquerque EX Mol Pharmacol; 1982 May; 21(3):637-47. PubMed ID: 6287200 [No Abstract] [Full Text] [Related]
10. The mechanism and site of action of ketamine on skeletal muscle. Maleque MA; Warnick JE; Albuquerque EX J Pharmacol Exp Ther; 1981 Dec; 219(3):638-45. PubMed ID: 6975368 [No Abstract] [Full Text] [Related]
11. Actions of the histrionicotoxins at the ion channel of the nicotinic acetylcholine receptor and at the voltage-sensitive ion channels of muscle membranes. Spivak CE; Maleque MA; Oliveira AC; Masukawa LM; Tokuyama T; Daly JW; Albuquerque EX Mol Pharmacol; 1982 Mar; 21(2):351-61. PubMed ID: 6285171 [TBL] [Abstract][Full Text] [Related]
12. The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Shaw KP; Aracava Y; Akaike A; Daly JW; Rickett DL; Albuquerque EX Mol Pharmacol; 1985 Dec; 28(6):527-38. PubMed ID: 2417099 [TBL] [Abstract][Full Text] [Related]
13. Competitive block and ion channel block as mechanisms of antagonist action on the skeletal muscle end-plate. Colquhoun D Adv Biochem Psychopharmacol; 1980; 21():67-80. PubMed ID: 6246760 [No Abstract] [Full Text] [Related]
14. Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle. Tsai MC; Albuquerque EX; Aronstam RS; Eldefrawi AT; Eldefrawi ME; Triggle DJ Mol Pharmacol; 1980 Sep; 18(2):159-66. PubMed ID: 6968397 [No Abstract] [Full Text] [Related]
15. Cholinergic receptor labelling specific irreversible binding of bromoacetylcholine to cholinergic receptors at neuromuscular junctions. Chiou CY Eur J Pharmacol; 1974 May; 26(2):268-76. PubMed ID: 4546755 [No Abstract] [Full Text] [Related]
16. [3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor. Eldefrawi ME; Eldefrawi AT; Aronstam RS; Maleque MA; Warnick JE; Albuquerque EX Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7458-62. PubMed ID: 6261260 [TBL] [Abstract][Full Text] [Related]
17. Agonist recognition site of the peripheral acetylcholine receptor ion channel complex differentiates the enantiomers of nicotine. Rozental R; Aracava Y; Scoble GT; Swanson KL; Wonnacott S; Albuquerque EX J Pharmacol Exp Ther; 1989 Nov; 251(2):395-404. PubMed ID: 2478693 [TBL] [Abstract][Full Text] [Related]
18. Physiological studies on the ionic channel of nicotinic neuromuscular synapses. Albuquerque EX; Oliveira AC Adv Cytopharmacol; 1979; 3():197-211. PubMed ID: 314230 [No Abstract] [Full Text] [Related]
19. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist. Varanda WA; Aracava Y; Sherby SM; VanMeter WG; Eldefrawi ME; Albuquerque EX Mol Pharmacol; 1985 Aug; 28(2):128-37. PubMed ID: 2410768 [TBL] [Abstract][Full Text] [Related]
20. Biochemical studies on the ionic channel of Torpedo acetylcholine receptor. Eldefrawi ME; Eldefrawi AT Adv Cytopharmacol; 1979; 3():213-23. PubMed ID: 382785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]